Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation

Plain-language summary

This study investigates molecular biological and molecular genetic monitoring of therapy in kidney transplant patients. It enrolls patients who have had a kidney transplant and provided consent. It is an observational (non-phase) study and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Odense University Hospital

Start date

1/1/2011

Estimated completion

3/31/2033

Countries

Denmark

Related genes

Locations

• Odense, Denmark

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients after kidney transplantation, male, female, informed consent

Exclusion Criteria:

* Deny of informed consent